Panbela Therapeutics, Inc. Common Stock
PBLA
PBLA was delisted on the 6th of March, 2024.
10 hedge funds and large institutions have $1.78M invested in Panbela Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
4% more capital invested
Capital invested by funds: $1.72M → $1.78M (+$63K)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$46.1K |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$46.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
M
Murchinson
Toronto,
Ontario, Canada
|
-$238K |
| 2 |
FPS
Fieldpoint Private Securities
Greenwich,
Connecticut
|
-$46.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IC
1
Ikarian Capital
Dallas,
Texas
| $750K | +$46.1K | +1 | +7% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $482K | – | – | – |
|
|
FPS
3
Fieldpoint Private Securities
Greenwich,
Connecticut
| $132K | -$46.1K | -1 | -25% |
|
|
BAMG
4
Brand Asset Management Group
Chesterfield,
Missouri
| $121K | – | – | – |
|
|
BFM
5
Boothbay Fund Management
New York
| $72K | – | – | – |
|
6
BlackRock
New York
| $61K | – | – | – |
|
|
BSW
7
Buckingham Strategic Wealth
Clayton,
Missouri
| $53K | – | – | – |
|
8
Verition Fund Management
Greenwich,
Connecticut
| $42K | – | – | – |
|
|
9
Geode Capital Management
Boston,
Massachusetts
| $29K | +$46.1K | +1 | New |
|
10
Morgan Stanley
New York
| $26K | – | – | – |
|
11
Osaic Holdings
Scottsdale,
Arizona
| $7K | – | – | – |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| $3K | – | – | – |
|
13
UBS Group
Zurich,
Switzerland
| $3K | – | – | – |
|
14
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $1K | – | – | – |
|
15
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
M
16
Murchinson
Toronto,
Ontario, Canada
| – | -$238K | -6 | Closed |
|
PBLA Hedge Fund Activity: Q1 2022 in Review
10 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Panbela Therapeutics, Inc. Common Stock (PBLA) for Q1 2022, worth a combined $1.78M — up 3.7% from $1.72M a quarter earlier.
Fund positioning in PBLA was balanced in Q1 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $46.1K. The largest seller was Murchinson, exiting entirely with an estimated $238K sold.
- 10 institutional investors held Panbela Therapeutics, Inc. Common Stock (PBLA) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $1.78M of Panbela Therapeutics, Inc. Common Stock stock for Q1 2022, up 3.7% quarter-over-quarter.
- 1 fund opened new Panbela Therapeutics, Inc. Common Stock positions in Q1 2022 and 1 closed out, a net change of 0 holders.
- The largest Panbela Therapeutics, Inc. Common Stock buyer in Q1 2022 was Geode Capital Management, an estimated $46.1K added.
- The largest Panbela Therapeutics, Inc. Common Stock seller in Q1 2022 was Murchinson, an estimated $238K sold.
Based on aggregated 13F filings for Q1 2022.